Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03817320
Brief Title: PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

First Submitted : January 22, 2019
First Submitted that Met QC Criteria : January 24, 2019
First Posted : January 25, 2019

Last Update Submitted that Met QC Criteria : May 21, 2019
Last Update Posted : May 23, 2019